TGFB1 and Hepatic fibrosis: These and also previous observations from our group demonstrated that an increase of ASM-activity, ceramide formation, TGF-β circulation and - ultimately - liver fibrosis in a mouse model of polymicrobial sepsis might be abrogated by ASM-inhibition (65).